A machine learning-driven framework accurately predicts MPA exposure and supports individualized dosing in childhood-onset LN.
Cambridge researchers map the convergence of biomarkers, digital phenotyping, and AI toward biologically grounded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results